"The EDSS has a number of limitations and may also measure changes that are not related to MS, such as older age and multiple ...

Contineum Therapeutics has concluded the targeted enrolment of 168 subjects in its Phase II trial of M1 receptor antagonist ...

Data from a systematic review of 30 real-world studies show comparable discontinuation rates of ocrelizumab to those in ...

After getting through a significant difficulty, many of us reject being described in favorable terms. Why don't we want to ...

Cohen also twice survived colon cancer, a blood clot in his lung and, in his later years, was left legally legally blind by the MS, according to People.

A team of doctors in Mumbai treated a 24-year-old engineering student who was suffering from multiple sclerosis, a chronic disease that affects the nervous system. For the patient, Sushant Chavan, ...

The world’s largest study of proteins circulating the human body will begin in the UK this month, with the aim of pinpointing how diseases develop and paving the way for simple blood tests to detect ...

"I tell my right foot to go somewhere, and it wants to go somewhere else. I gotta be very precise about, moving around, especially when I start moving fast on stage." ...

SPRINGFIELD, Ill. – The Illinois Department of Public Health (IDPH) has approved four new conditions for treatment with ...

For patients with relapsed or refractory multiple myeloma, talquetamab plus teclistamab shows response in a high percentage ...

A nutrient deficiency occurs when your body doesn’t get enough of a particular nutrient, whether that’s essential vitamins or ...

Patients with multiple myeloma (MM) can experience diminished immune responses during prolonged treatment; however, mRNA ...